SCHEMBL26439055

SCHEMBL26439055

CCCC1CCNC(C)C1C(C)C

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 1/20 0.31
NOS2 P35228 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL292390 0.80
SCHEMBL25597554 0.75 CA1 (0.33) CA1CA2CA4
SCHEMBL23373642 0.71
SCHEMBL24835768 0.70
SCHEMBL15504872 0.68 CA1 (0.43) NOS1NOS2CA1CA2CA4
SCHEMBL294147 0.68 CYP1A2 (0.37)
SCHEMBL21077350 0.68 CA1 (0.43) NOS1NOS2CA1CA2CA4
SCHEMBL15534260 0.68 CA1 (0.31) CA1CA2CA4
Hydrochloric Acid SCHEMBL991508 0.67 CA1 (0.42) CA1CA2CA4
SCHEMBL26214980 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023066357-A1 FUSED CYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2023-04-27 WO disclosed
WO-2023066371-A1 NITROGEN-CONTAINING TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2023-04-27 WO disclosed